SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Full Alliance International LTD

(Last) (First) (Middle)
RM 1701, WING TUCK COMMERCIAL CENTRE
183 WING LOK STREET

(Street)
SHEUNG WAN K3 00000

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/17/2008
3. Issuer Name and Ticker or Trading Symbol
Yongye Biotechnology International, Inc. [ YGYB.OB ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.001 6,748,107(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Pursuant to a Make Good Escrow Agreement, dated as of April 17, 2008, by and among Full Alliance International Limited, ROTH Capital Partners, LLC and Tri-State Title & Escrow LLC as the Escrow Agent, 2,000,000 shares of Common Stock held by Full Alliance International Limited have been delivered to the Escrow Agent to be held as security for the achievement by Yongye Biotechnology International, Inc. of certain net income thresholds. Therefore, Full Alliance International Limited has the power to direct the voting of 6,748,107 shares of Common Stock and disposition of 4,748,107 shares of Common Stock.
/s/ Yayoi Shionoiri, Attorney-in-fact 06/17/2008
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.